510(k) Report

510(k) · Cleared

Cleared

Hylatopicplus Cream

K110727510(k) SpecialCleared Apr 1, 201116-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Precision Dermatology Incorporated · FRO Dressing, Wound, Drug

Cleared on Apr 1, 2011 as substantially equivalent to K093051 (Collegium Pharmaceutical Incorporated, 2009) after a 16-day review. Its family tree reaches back 6 generations to 1996. 4 later devices descend from it.

Decided
Apr 1, 2011
Review
16 days
Class
Class U
Product code
FRO
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K961758 (1996). 8 ancestors in all. 4 later devices descend from it, 4 citing it directly.

  1. Root · 6 generations backK961758 Carasyn Hydrogel Wound ProductsCarrington Laboratories, Inc. · 1996
  2. 5 generations backK024367 Sinclair Wound and Skin EmulsionSinclair Pharmaceuticals, Ltd. · 2003
  3. 4 generations backK041342 Impruv a.I. Cream Wound and Skin EmulsionStiefel Laboratories, Inc. · 2005
  4. 3 generations backK060272 Locobase Wound and Skin EmulsionFerndale Laboratories, Inc. · 2007
  5. 2 generations backK083024 Hylatopic Emollient FoamCollegium Pharmaceutical Incorporated · 2009
  6. 1 generation backK093051 Hylatopic Plus Emollient FoamCollegium Pharmaceutical Incorporated · 2009
  7. This deviceK110727 Hylatopicplus CreamPrecision Dermatology Incorporated · 2011
  8. Descendant · cites it directly · 0 of its ownK150914 Dash-Topic Plus CreamFounders Science Group, LLC · 2016
  9. Descendant · cites it directly · 0 of its ownK132329 Nivatopic PlusNivagen Pharmaceuticals, Inc. · 2013
  10. Descendant · cites it directly · 0 of its ownK123678 Hyalmix CreamIgi Laboratories, Inc. · 2013
  11. Descendant · cites it directly · 0 of its ownK121559 Hylatopicplus LotionPrecision Dermatology Incorporated · 2012

Most influential descendants

Showing 4 of 4 · See all
  • K150914Dash-Topic Plus CreamFounders Science Group, LLC · 2016 · cites it directly0descendants
  • K132329Nivatopic PlusNivagen Pharmaceuticals, Inc. · 2013 · cites it directly0descendants
  • K123678Hyalmix CreamIgi Laboratories, Inc. · 2013 · cites it directly0descendants
  • K121559Hylatopicplus LotionPrecision Dermatology Incorporated · 2012 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K961758Carasyn Hydrogel Wound ProductsCarrington Laboratories, Inc.1996—
−5K024367Sinclair Wound and Skin EmulsionSinclair Pharmaceuticals, Ltd.2003—
−4K041342Impruv a.I. Cream Wound and Skin EmulsionStiefel Laboratories, Inc.2005—
−3K060272Locobase Wound and Skin EmulsionFerndale Laboratories, Inc.2007—
−2K083024Hylatopic Emollient FoamCollegium Pharmaceutical Incorporated2009—
−1K093051Hylatopic Plus Emollient FoamCollegium Pharmaceutical Incorporated2009—
0 (this device)K110727Hylatopicplus CreamPrecision Dermatology Incorporated2011—
+1K150914Dash-Topic Plus CreamFounders Science Group, LLC2016—
+1K132329Nivatopic PlusNivagen Pharmaceuticals, Inc.2013—
+1K123678Hyalmix CreamIgi Laboratories, Inc.2013—
+1K121559Hylatopicplus LotionPrecision Dermatology Incorporated2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201320
201610
FIG. 1 — Lineage of K110727, 1996–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRO device

  1. #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K093051Hylatopic Plus Emollient Foam
Summary page 1
…fied Product code: MGQ Devices to Which New Device is Substantially Equivalent HylatopiCTM Plus Emollient Foam cleared December 7 th, 2009 under 5 10O(k) K09305 1, from Collegium Pharmaceutical, Inc. PreCision Dermatology acquired the legal rights to 5 10(k) K09305 1 and thus PreCision has f…
Collegium Pharmaceutical Incorporated2009—

Also cleared against K093051: 1 other device →

What descends from it? (4)

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K150914Dash-Topic Plus CreamFounders Science Group, LLC20160
K132329Nivatopic PlusNivagen Pharmaceuticals, Inc.20130
K123678Hyalmix CreamIgi Laboratories, Inc.20130
K121559Hylatopicplus LotionPrecision Dermatology Incorporated20120

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 6 companies; a new generation was cleared every 2.0 years on median.
  • None of the 8 ancestors has a recall.
  • Of its descendants, K150914 (Founders Science Group, LLC, 2016) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K093051.

How does its category compare?

All FRO devices

FRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · FRO

11in 2025

2007: 292008: 262009: 312010: 312011: 272012: 242013: 192014: 222015: 282016: 282017: 232018: 202019: 162020: 122021: 82022: 92023: 182024: 242025: 112026 (partial year): 17
2007high 31 (2009) · low 8 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRO

176in 2025

2007: 187 days median2008: 130 days median2009: 136 days median2010: 146 days median2011: 177 days median2012: 96 days median2013: 194 days median2014: 214 days median2015: 249 days median2016: 222 days median2017: 147 days median2018: 206 days median2019: 270 days median2020: 226 days median2021: 275 days median2022: 332 days median2023: 283 days median2024: 263 days median2025: 176 days median2026 (partial year): 254 days median
2007high 332 (2022) · low 96 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRO

2in 2024

2007: 42008: 12009: 12011: 42013: 12014: 12015: 22016: 32017: 12019: 12021: 62022: 22023: 2, 2 Class I2024: 22026 (partial year): 2
2007high 6 (2021) · low 0 (2010)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · FRO

192in 2025

2007: 552008: 302009: 452010: 1222011: 422012: 652013: 1392014: 2692015: 2972016: 1472017: 1492018: 1282019: 1362020: 1392021: 1832022: 1762023: 1982024: 2322025: 192
2007high 297 (2015) · low 30 (2008)2025

MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200729187455
200826130130
200931136145
2010311460122
201127177442
20122496065
2013191941139
2014222141269
2015282492297
2016282223147
2017231471149
2018202060128
2019162701136
2020122260139
202182756183
202293322176
2023182832 (2)198
2024242632232
2025111760192
2026172542—

What is it indicated for?

Under the supervision of a healthcare professional, HylatopicPlus Cream is indicated to

manage and relieve the burning, itching and pain experienced with various types of

dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation

dermatitis. HylatopicPlus Cream also helps to relieve dry, waxy skin by maintaining a

moist wound & skin environment, which is beneficial to the healing process.

HylatopiePlus Cream is indicated for use in:

Atopic Dermatitis

Allergic Contact Dermatitis

Radiation Dermatitis

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K110727: Hylatopicplus Cream.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K110727

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026